vs
百特国际(BAX)与CSX Corporation(CSX)财务数据对比。点击上方公司名可切换其他公司
CSX Corporation的季度营收约是百特国际的1.3倍($3.5B vs $2.7B),CSX Corporation净利率更高(23.2% vs -0.6%,领先23.7%),百特国际同比增速更快(3.0% vs 1.7%),CSX Corporation自由现金流更多($793.0M vs $76.0M),过去两年CSX Corporation的营收复合增速更高(-3.0% vs -15.8%)
百特国际是总部位于美国伊利诺伊州迪尔菲尔德的跨国医疗健康企业,业务布局覆盖全球众多市场,专注于研发、生产及销售各类医疗相关产品与解决方案,为全球医疗机构和患者提供专业可靠的医疗支持。
CSX运输是美国一级货运铁路企业,业务覆盖美国东部区域及加拿大安大略省、魁北克省,运营铁路总里程约3.4万公里,隶属于总部位于佛罗里达州杰克逊维尔市的财富500强企业CSX Corporation,是其旗下核心子公司。
BAX vs CSX — 直观对比
营收规模更大
CSX
是对方的1.3倍
$2.7B
营收增速更快
BAX
高出1.3%
1.7%
净利率更高
CSX
高出23.7%
-0.6%
自由现金流更多
CSX
多$717.0M
$76.0M
两年增速更快
CSX
近两年复合增速
-15.8%
损益表 — Q1 FY2026 vs Q1 FY2026
| 指标 | ||
|---|---|---|
| 营收 | $2.7B | $3.5B |
| 净利润 | $-15.0M | $807.0M |
| 毛利率 | 33.0% | — |
| 营业利润率 | 2.4% | 36.0% |
| 净利率 | -0.6% | 23.2% |
| 营收同比 | 3.0% | 1.7% |
| 净利润同比 | — | 24.9% |
| 每股收益(稀释后) | $-0.03 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比,按日历期对齐,财年错位的公司也能正确匹配
营收
BAX
CSX
| Q1 26 | $2.7B | $3.5B | ||
| Q4 25 | $3.0B | $3.5B | ||
| Q3 25 | $2.8B | $3.6B | ||
| Q2 25 | $2.8B | $3.6B | ||
| Q1 25 | $2.6B | $3.4B | ||
| Q4 24 | $533.0M | $3.5B | ||
| Q3 24 | $2.7B | $3.6B | ||
| Q2 24 | $3.8B | $3.7B |
净利润
BAX
CSX
| Q1 26 | $-15.0M | $807.0M | ||
| Q4 25 | $-1.1B | $720.0M | ||
| Q3 25 | $-46.0M | $694.0M | ||
| Q2 25 | $91.0M | $829.0M | ||
| Q1 25 | $126.0M | $646.0M | ||
| Q4 24 | $-512.0M | $720.0M | ||
| Q3 24 | $140.0M | $894.0M | ||
| Q2 24 | $-314.0M | $963.0M |
毛利率
BAX
CSX
| Q1 26 | 33.0% | — | ||
| Q4 25 | 19.4% | — | ||
| Q3 25 | 33.5% | — | ||
| Q2 25 | 35.3% | — | ||
| Q1 25 | 32.8% | — | ||
| Q4 24 | 25.0% | — | ||
| Q3 24 | 38.3% | — | ||
| Q2 24 | 37.5% | — |
营业利润率
BAX
CSX
| Q1 26 | 2.4% | 36.0% | ||
| Q4 25 | -24.5% | 31.6% | ||
| Q3 25 | 6.1% | 30.3% | ||
| Q2 25 | 6.8% | 35.9% | ||
| Q1 25 | 2.2% | 30.4% | ||
| Q4 24 | -25.5% | 30.8% | ||
| Q3 24 | 5.7% | 37.4% | ||
| Q2 24 | -5.0% | 39.1% |
净利率
BAX
CSX
| Q1 26 | -0.6% | 23.2% | ||
| Q4 25 | -37.9% | 20.5% | ||
| Q3 25 | -1.6% | 19.3% | ||
| Q2 25 | 3.2% | 23.2% | ||
| Q1 25 | 4.8% | 18.9% | ||
| Q4 24 | -96.1% | 20.3% | ||
| Q3 24 | 5.2% | 24.7% | ||
| Q2 24 | -8.2% | 26.0% |
每股收益(稀释后)
BAX
CSX
| Q1 26 | $-0.03 | — | ||
| Q4 25 | $-2.21 | $0.39 | ||
| Q3 25 | $-0.09 | $0.37 | ||
| Q2 25 | $0.18 | $0.44 | ||
| Q1 25 | $0.25 | $0.34 | ||
| Q4 24 | $-0.99 | $0.38 | ||
| Q3 24 | $0.27 | $0.46 | ||
| Q2 24 | $-0.62 | $0.49 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | ||
|---|---|---|
| 现金及短期投资手头流动性 | — | $1.1B |
| 总债务越低越好 | — | $18.9B |
| 股东权益账面价值 | — | $13.6B |
| 总资产 | — | $44.2B |
| 负债/权益比越低杠杆越低 | — | 1.39× |
8季度趋势,按日历期对齐
现金及短期投资
BAX
CSX
| Q1 26 | — | $1.1B | ||
| Q4 25 | $2.0B | $5.0M | ||
| Q3 25 | $1.7B | $6.0M | ||
| Q2 25 | $1.7B | $6.0M | ||
| Q1 25 | $2.3B | $8.0M | ||
| Q4 24 | $1.8B | $72.0M | ||
| Q3 24 | $1.4B | $12.0M | ||
| Q2 24 | $2.1B | $4.0M |
总债务
BAX
CSX
| Q1 26 | — | $18.9B | ||
| Q4 25 | $9.5B | $18.2B | ||
| Q3 25 | — | $18.6B | ||
| Q2 25 | — | $18.6B | ||
| Q1 25 | — | $18.5B | ||
| Q4 24 | $10.4B | $17.9B | ||
| Q3 24 | $10.4B | $18.5B | ||
| Q2 24 | $10.4B | $18.0B |
股东权益
BAX
CSX
| Q1 26 | — | $13.6B | ||
| Q4 25 | $6.1B | $13.2B | ||
| Q3 25 | $7.2B | $12.8B | ||
| Q2 25 | $7.3B | $12.4B | ||
| Q1 25 | $7.1B | $12.2B | ||
| Q4 24 | $7.0B | $12.5B | ||
| Q3 24 | $7.9B | $12.9B | ||
| Q2 24 | $7.6B | $12.6B |
总资产
BAX
CSX
| Q1 26 | — | $44.2B | ||
| Q4 25 | $20.1B | $43.7B | ||
| Q3 25 | $21.1B | $43.3B | ||
| Q2 25 | $21.0B | $42.9B | ||
| Q1 25 | $21.3B | $43.2B | ||
| Q4 24 | $25.8B | $42.8B | ||
| Q3 24 | $26.7B | $43.1B | ||
| Q2 24 | $26.3B | $42.4B |
负债/权益比
BAX
CSX
| Q1 26 | — | 1.39× | ||
| Q4 25 | 1.55× | 1.38× | ||
| Q3 25 | — | 1.45× | ||
| Q2 25 | — | 1.50× | ||
| Q1 25 | — | 1.52× | ||
| Q4 24 | 1.49× | 1.43× | ||
| Q3 24 | 1.33× | 1.43× | ||
| Q2 24 | 1.37× | 1.42× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | ||
|---|---|---|
| 经营现金流最新季度 | — | $1.3B |
| 自由现金流经营现金流 - 资本支出 | $76.0M | $793.0M |
| 自由现金流率自由现金流/营收 | 2.8% | 22.8% |
| 资本支出强度资本支出/营收 | 5.1% | — |
| 现金转化率经营现金流/净利润 | — | 1.58× |
| 过去12个月自由现金流最近4个季度 | — | $2.0B |
8季度趋势,按日历期对齐
经营现金流
BAX
CSX
| Q1 26 | — | $1.3B | ||
| Q4 25 | $584.0M | $1.4B | ||
| Q3 25 | $237.0M | $1.3B | ||
| Q2 25 | $217.0M | $635.0M | ||
| Q1 25 | $-193.0M | $1.3B | ||
| Q4 24 | $488.0M | $1.4B | ||
| Q3 24 | $253.0M | $1.7B | ||
| Q2 24 | $115.0M | $1.1B |
自由现金流
BAX
CSX
| Q1 26 | $76.0M | $793.0M | ||
| Q4 25 | — | $709.0M | ||
| Q3 25 | — | $607.0M | ||
| Q2 25 | — | $-141.0M | ||
| Q1 25 | — | $536.0M | ||
| Q4 24 | — | $550.0M | ||
| Q3 24 | — | $1.1B | ||
| Q2 24 | — | $547.0M |
自由现金流率
BAX
CSX
| Q1 26 | 2.8% | 22.8% | ||
| Q4 25 | — | 20.2% | ||
| Q3 25 | — | 16.9% | ||
| Q2 25 | — | -3.9% | ||
| Q1 25 | — | 15.7% | ||
| Q4 24 | — | 15.5% | ||
| Q3 24 | — | 29.3% | ||
| Q2 24 | — | 14.8% |
资本支出强度
BAX
CSX
| Q1 26 | 5.1% | — | ||
| Q4 25 | — | 19.3% | ||
| Q3 25 | — | 20.4% | ||
| Q2 25 | — | 21.7% | ||
| Q1 25 | — | 21.0% | ||
| Q4 24 | — | 23.7% | ||
| Q3 24 | — | 17.3% | ||
| Q2 24 | — | 14.6% |
现金转化率
BAX
CSX
| Q1 26 | — | 1.58× | ||
| Q4 25 | — | 1.93× | ||
| Q3 25 | — | 1.93× | ||
| Q2 25 | 2.38× | 0.77× | ||
| Q1 25 | -1.53× | 1.94× | ||
| Q4 24 | — | 1.93× | ||
| Q3 24 | 1.81× | 1.89× | ||
| Q2 24 | — | 1.13× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图